Article
Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study.
Cardiovascular drugs and therapy - 1 Dec 2022
Montarello Nicholas J, Singh Kuljit, Sinhal Ajay, Wong Dennis T L, Alcock Richard, Rajendran Sharmalar, Dautov Rustem, Barlis Peter, Patel Sanjay, Nidorf Stefan M, Thompson Peter L, Salagaras Thalia, Butters Julie, Nerlekar Nitesh, Di Giovanni Giuseppe, Ottaway Juanita L, Nicholls Stephen J, Psaltis Peter J
Abstract excerpt
INTRODUCTION: Recurrent event rates after myocardial infarction (MI) remain unacceptably high, in part because of the continued growth and destabilization of residual coronary atherosclerotic plaques, which may occur despite lipid-lowering therapy. Inflammation is an important contributor to this ongoing risk. Recent studies have shown that the broad-acting anti-inflammatory agent, colchicine, may reduce adverse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
